Worldwide pharmacovigilance systems and tolrestat withdrawal

SIOI Policy on Sugar Intake: Limiting Free Sugars from Earliest Days of Life to Prevent Caries, Specific Non-Communicable Diseases, and Tumors.

European journal of paediatric dentistry·2025

Real-world dental health of Ukrainian war refugee children and adolescents in Umbria, Italy: preliminary data.

BMC oral health·2025

Oral health in patients with cleft lip and palate: a systematic literature review and meta-analysis of periodontal and dental disease and oral microbiota (part 1).

BMC oral health·2025

Laser and remineralising agents in dental erosion: a systematic review and meta-analysis.

European journal of paediatric dentistry·2024

Covid-19 pandemic and clinical activity stop: oral health study in a group of children.

European journal of paediatric dentistry·2024

Autism spectrum disorder and paediatric dentistry: A narrative overview of intervention strategy and introduction of an innovative technological intervention method.

European journal of paediatric dentistry·2022

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Sodium polyphosphate, a new drug for treatment of atopic dermatitis: basic considerations and clinical case studies.

Biomaterials science·2026

The impact of parathyroid hormone replacement with palopegteriparatide on synthesis of 1,25-dihydroxy vitamin D in hypoparathyroidism.

Expert review of clinical pharmacology·2026

Association of serum testosterone concentrations with central adiposity in men who inject heroin in Mombasa County, Kenya.

The Pan African medical journal·2026

Sex-Specific Effects of the Atypical Antipsychotic Risperidone on Performance in a Risky Decision-making Task.

Behavioural brain research·2026

Preliminary exploration of effects of the JAK inhibitor tofacitinib on pyoderma gangrenosum: In vitro inhibition of NETs and Th17 differentiation.

Molecular immunology·2026

SAFETY OF TAMSULOSIN ALONE OR IN COMBINATION WITH 5Α-REDUCTASE INHIBITORS ON LIPID PROFILE, RENAL FUNCTION, AND LIVER PARAMETERS.

Georgian medical news·2026

Related Experiment Videos

Worldwide pharmacovigilance systems and tolrestat withdrawal

Related Concept Videos

SIOI Policy on Sugar Intake: Limiting Free Sugars from Earliest Days of Life to Prevent Caries, Specific Non-Communicable Diseases, and Tumors.

Real-world dental health of Ukrainian war refugee children and adolescents in Umbria, Italy: preliminary data.

Oral health in patients with cleft lip and palate: a systematic literature review and meta-analysis of periodontal and dental disease and oral microbiota (part 1).

Laser and remineralising agents in dental erosion: a systematic review and meta-analysis.

Covid-19 pandemic and clinical activity stop: oral health study in a group of children.

Autism spectrum disorder and paediatric dentistry: A narrative overview of intervention strategy and introduction of an innovative technological intervention method.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Sodium polyphosphate, a new drug for treatment of atopic dermatitis: basic considerations and clinical case studies.

The impact of parathyroid hormone replacement with palopegteriparatide on synthesis of 1,25-dihydroxy vitamin D in hypoparathyroidism.

Association of serum testosterone concentrations with central adiposity in men who inject heroin in Mombasa County, Kenya.

Sex-Specific Effects of the Atypical Antipsychotic Risperidone on Performance in a Risky Decision-making Task.

Preliminary exploration of effects of the JAK inhibitor tofacitinib on pyoderma gangrenosum: In vitro inhibition of NETs and Th17 differentiation.

SAFETY OF TAMSULOSIN ALONE OR IN COMBINATION WITH 5Α-REDUCTASE INHIBITORS ON LIPID PROFILE, RENAL FUNCTION, AND LIVER PARAMETERS.

Related Experiment Videos

Worldwide pharmacovigilance systems and tolrestat withdrawal

Related Concept Videos

Related Articles